Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.060 GeneticVariation disease BEFREE While homozygous CDKN2A/B loss has been directly associated with Richter transformation, we did not find this association for heterozygous loss of CDKN2A/B. 31467127 2019
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.060 Biomarker disease BEFREE Molecular lesions of regulators of tumor suppression (TP53), cell cycle (CDKN2A), and cell proliferation (NOTCH1, MYC) overall account for ~90% of RS and may be responsible for the aggressive clinical phenotype observed in this disease because of the combined effect of chemoresistance and rapid disease kinetics. 27040710 2016
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.060 Biomarker disease BEFREE Molecular lesions of tumor suppression regulators (TP53), cell cycle (CDKN2A) and cell proliferation (NOTCH1, MYC) overall account for ∼90% of RS and may be responsible for its aggressive clinical phenotype. 27742070 2016
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.060 Biomarker disease BEFREE In particular, disruption of the CDKN2A/B cell cycle regulator is associated with ∼30% of RS cases. 24127483 2013
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.060 AlteredExpression disease BEFREE To investigate the role of the cell cycle regulators p21(Waf1), p27(Kip1), retinoblastoma (Rb), and cyclin D1 in Richter's transformation of chronic lymphocytic leukemia (CLL), we analyzed 19 CLL and eight Richter's syndrome (RS) tumors, previously characterized for p53 and ARF/INK4a abnormalities. p21(Waf1)immunohistochemical expression was negative in 12 of 15 CLL (80%), whereas it was moderate or strong in three of seven RS (43%). p21(Waf1) gene was in germline configuration in all the tumors analyzed. 12040434 2002
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.060 Biomarker disease BEFREE Sequential samples of the indolent and transformed phase of three cases showed the presence of p16(INK4a) deletions in the Richter's syndrome but not in the CLL component of two cases, whereas in a follicular lymphoma the deletion was present in both the follicular tumor and in the diffuse large-cell lymphoma. 9531609 1998